1. Home
  2. SVC vs IMMP Comparison

SVC vs IMMP Comparison

Compare SVC & IMMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

SVC

Service Properties Trust

HOLD

Current Price

$2.27

Market Cap

361.4M

Sector

Real Estate

ML Signal

HOLD

Logo Immutep Limited

IMMP

Immutep Limited

HOLD

Current Price

$2.67

Market Cap

410.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
SVC
IMMP
Founded
1995
1987
Country
United States
Australia
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
361.4M
410.7M
IPO Year
1995
2012

Fundamental Metrics

Financial Performance
Metric
SVC
IMMP
Price
$2.27
$2.67
Analyst Decision
Hold
Buy
Analyst Count
3
1
Target Price
$2.50
$10.00
AVG Volume (30 Days)
1.6M
150.3K
Earning Date
05-29-2026
01-01-0001
Dividend Yield
1.74%
N/A
EPS Growth
26.95
N/A
EPS
N/A
N/A
Revenue
$1,814,838,000.00
N/A
Revenue This Year
N/A
$372.23
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$1.55
$1.32
52 Week High
$3.08
$3.53

Technical Indicators

Market Signals
Indicator
SVC
IMMP
Relative Strength Index (RSI) 58.84 43.35
Support Level $2.22 $2.56
Resistance Level $2.43 $2.71
Average True Range (ATR) 0.11 0.13
MACD 0.01 -0.01
Stochastic Oscillator 53.52 11.59

Price Performance

Historical Comparison
SVC
IMMP

About SVC Service Properties Trust

Service Properties Trust is a real estate investment trust that owns hotel properties. These properties are located in the United States, along with Canada and Puerto Rico. The company operates through its hotel investment unit and net lease investments. The firm derives the majority of its revenue from the hotel real estate investments unit. The hotels are distinguished between their service levels, which include full service, select service, and extended stay; and chain scale, which includes luxury, upper upscale, upscale, upper midscale, and midscale. The hotels are extended stay or upscale. Some of the hotel brands include Courtyard by Marriott, Royal Sonesta, Crowne Plaza Hotels & Resorts, and Hyatt Place.

About IMMP Immutep Limited

Immutep Ltd is a Phase three clinical biotechnology company developing novel Lymphocyte Activation Gene-3 (LAG-3) related immunotherapies for cancer and autoimmune disease. It has a diversified product portfolio that harnesses LAG-3's ability to stimulate the body's immune response to fight cancer or suppress the immune system to treat autoimmune disease. The company is focused on advancing its product candidate, eftilagimod alfa (efti), through its registrational Phase three clinical trial towards marketing approval in first-line non-small cell lung cancer (1L NSCLC). The other product candidates in its portfolio include TACTI-004, TACTI-003, AIPAC-003, TACTI-002, INSIGHT-005, and others, being developed as potential therapies for various cancers and autoimmune diseases.

Share on Social Networks: